{"nct_id":"NCT00729742","title":"Phase I Imaging Study Evaluating Dalotuzumab (MK0646) in Combination With Erlotinib for Patients With Non-Small Cell Lung Cancer (MK-0646-008)","status":"COMPLETED","status_verified_date":"2016-04","start_date":"2009-02","start_date_type":null,"primary_completion_date":"2010-06","primary_completion_date_type":"ACTUAL","completion_date":"2011-05","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["MRK"]}